To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05038735
Title Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-postitive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. (EPIK-B5)
Acronym EPIK-B5
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries SVK | ROU | POL | ITA | IRL | HUN | GRC | FRA | FIN | ESP | DNK | DEU | CZE | CAN | BGR | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Sint Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Sofia 1750 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Calgary Alberta T2N 5G2 Canada Details
Novartis Investigative Site Oshawa Ontario L1G 2B9 Canada Details
Novartis Investigative Site Ottawa Ontario K1H 8L6 Canada Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Novy Jicin Czech Republic 74101 Czechia Details
Novartis Investigative Site Praha 10 100 34 Czechia Details
Novartis Investigative Site Praha 4 140 59 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Aalborg DK 9000 Denmark Details
Novartis Investigative Site Kobenhavn O DK-2100 Denmark Details
Novartis Investigative Site Odense C DK 5000 Denmark Details
Novartis Investigative Site Helsinki 00029 Finland Details
Novartis Investigative Site Tampere FIN-33521 Finland Details
Novartis Investigative Site Besancon Cedex 25030 France Details
Novartis Investigative Site Clermont-Ferrand 63011 France Details
Novartis Investigative Site La Roche sur Yon Cedex 85925 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Montpellier 34298 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Valenciennes 59300 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Augsburg 86150 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Luebeck 23538 Germany Details
Novartis Investigative Site Athens GR 115 22 Greece Details
Novartis Investigative Site Patras 265 00 Greece Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Gyor H-9024 Hungary Details
Novartis Investigative Site Dublin 4 DO4 Ireland Details
Novartis Investigative Site Dublin D03 VX82 Ireland Details
Novartis Investigative Site Dublin DUBLIN 9 Ireland Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Palermo PA 90127 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Terni TR 05100 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Bydgoszcz 85 796 Poland Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Opole 45 054 Poland Details
Novartis Investigative Site Coimbra 3000-075 Portugal Details
Novartis Investigative Site Lisboa 1099 023 Portugal Details
Novartis Investigative Site Lisboa 1400-038 Portugal Details
Novartis Investigative Site Lisboa 1500 650 Portugal Details
Novartis Investigative Site Lisboa 1649 035 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Floresti Cluj 407280 Romania Details
Novartis Investigative Site Craiova Dolj 200347 Romania Details
Novartis Investigative Site Constanta 905900 Romania Details
Novartis Investigative Site Timisoara 300425 Romania Details
Novartis Investigative Site Bratislava Slovak Republic 83310 Slovakia Details
Novartis Investigative Site Bratislava 812 50 Slovakia Details
Novartis Investigative Site Kosice 041 91 Slovakia Details
Novartis Investigative Site Malaga Andalucia 29011 Spain Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Oviedo Asturias 33011 Spain Details
Novartis Investigative Site Jerez Cadiz 11407 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Badajoz Extremadura 06080 Spain Details
Novartis Investigative Site A Coruna Galicia 15009 Spain Details
Novartis Investigative Site Pozuelo de Alarcon Madrid 28223 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field